Alcon News

General insurance brokerage Anthony Clark International Insurance Brokers Ltd on Friday reported net earnings of CAD89,761 for the third quarter ended 30 September 2009, compared to a net loss of CAD497,190 last year.

American blue chips have been the backbone of many investors' portfolios for the past century.

Expectations are running high that the Obama administration will put forward another major stimulus package by early 2010.

Article by Tony Watson and Jane Owen On 12 November 2009, the Federal Court of Australia delivered its judgment in Alcon Inc v Bausch & Lomb Pty Ltd [2009] FCA 1299 .

Is the recent market softness something to be worried about? Not if U.S. President Barack Obama & Co.

Ralcorp Holdings Inc. said Tuesday its fiscal fourth-quarter profit nearly doubled on higher sales and a boost from its acquisition of Post Foods.

Here's what Jim Cramer had to say about some of the stocks that callers offered up during the "Mad Money Lightning Round" Monday evening.

Dish Network says third-quarter profit fell 12 percent as its subscriber base edged up.

Navigational device maker Garmin Ltd. says profits surged in the third quarter as improved pricing and lower costs offset a drop in sales.

Eye drug maker Alcon Inc. said its profit fell 18 percent in the third quarter compared with a year ago, when it received a large tax benefit.

Among the earnings stories for Wednesday, Oct. 28, from AP Financial News: OCEANPORT, N.J. - CommVault Systems Inc.

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions.

Allergan Inc. said Thursday its third-quarter profit rose 8 percent on a boost in eye care and Botox wrinkle treatment sales.

Alcon, Inc. reported global sales rose 5.9 percent to $1,614 million for the third quarter of 2009, or a 9.0 percent increase excluding the impact of foreign exchange fluctuations.

Alcon Inc October 28, 2009 8:30 a.m. ET Executives Doug MacHatton - VP, Treasury and Investor and Public Relations Kevin Buehler - President and CEO Rick Croarkin - SVP and CFO Dr.

Back in August, I advised investors to load up on Alcon , the eye care company because, this New Year's, Novartis could be forced to buy all of Nestle's approximately 150 million at a $181 price.

Potentia Pharmaceuticals, a privately-held biotechnology company developing medicines for the treatment of age-related macular degeneration , announced today that it has entered into licensing and purchase option agreements with Alcon Research, Ltd., a wholly-owned subsidiary of Alcon, Inc.

Global food giant Nestl SA on Thursday increased hopes it would soon part with a 52% stake in eye treatment products unit Alcon Inc.

Novartis, the Swiss pharmaceutical giant, on Thursday said its third-quarter profit was virtually unchanged, as growing sales of cancer and hypertension medications were offset by charges and declining vaccine sales.

NovaBay Pharmaceuticals, Inc. , a clinical stage company developing non-antibiotic anti-infective compounds for the treatment or prevention of a wide range of bacterial, viral, and fungal infections, today announced that the company has named Mark Anderson, Ph.D. as chief scientific officer, a new position for the company.